Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Pharmaceutical Statistics|September 22, 2021
A note on confidence intervals for the restricted mean survival time based on transformations in small sample sizeHiroya Hashimoto, Akiko Kada
Nagoya Journal of Medical Science|September 15, 2018
An open-label, single-arm study of CRYO2 for tissue removal at the site of central airway obstruction or stenosis: study protocolHideo Saka, Akiko Kada
Neurologia Medico-Chirurgica|September 30, 2016
Status and Future Perspectives of Utilizing Big Data in Neurosurgical and Stroke ResearchAtaru Nishimura, Kunihiro Nishimura, Akiko Kada, et al.
The Journal of International Medical Research|March 2, 2018
Public awareness of the need to call emergency medical services following the onset of acute myocardial infarction and associated factors in JapanNaohiro Yonemoto, Akiko Kada, Hiroyuki Yokoyama, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 17, 2008
[Aspirin resistance]Shigeki Miyata, Toshiyuki Miyata, Akiko Kada, et al.
BMJ Open|February 21, 2019
Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocolMorihiro Matsuda, Akiko Kada, Akiko M Saito, et al.
In Vivo (Athens, Greece)|September 1, 2019
An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of Central Airway Obstruction or StenosisHideo Saka, Masahide Oki, Akiko Kada, et al.
Clinical Lung Cancer|May 31, 2021
A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study ProtocolYoshihito Kogure, Hiroya Hashimoto, Masahide Oki
Acta Medica Okayama|February 27, 2020
A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in ChildrenAkiko Kada, Reiji Fukano, Tetsuya Mori, et al.
JTO Clinical and Research Reports|June 12, 2023
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL StudyYoshihito Kogure, Akiko Kada, Hiroya Hashimoto, et al.
Pageof 18